Sorrento Therapeutics, Inc. financial reports, Sorrento Therapeutics, Inc. annual revenue in 2024. When does Sorrento Therapeutics, Inc. report revenue?
Sorrento Therapeutics, Inc. total revenue, net income and dynamics of changes in US dollar today
Net revenue Sorrento Therapeutics, Inc. is now 14 255 000 $. Information about net revenue is taken from open sources. Net income Sorrento Therapeutics, Inc. - 2 510 000 $. Information about net income is used from open sources. The dynamics of Sorrento Therapeutics, Inc. net income went up. The change was 74 012 000 $. The financial graph of Sorrento Therapeutics, Inc. shows the values and changes of such indicators: total assets, net income, net revenue. Sorrento Therapeutics, Inc. financial report on a graph in real time displays the dynamics, i.e. change in fixed assets of the company. A graph of the value of all Sorrento Therapeutics, Inc. assets is presented in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
14 255 000 $
+132.05 % ↑
2 510 000 $
-
31/12/2020
11 505 000 $
+66.04 % ↑
-71 502 000 $
-
30/09/2020
11 753 000 $
+103.41 % ↑
-84 023 000 $
-
30/06/2020
9 007 000 $
+39.06 % ↑
-77 740 000 $
-
30/09/2019
5 778 000 $
-
-64 415 000 $
-
30/06/2019
6 477 000 $
-
-56 762 000 $
-
31/03/2019
6 143 000 $
-
-108 071 000 $
-
31/12/2018
6 929 000 $
-
-49 776 000 $
-
30/09/2018
4 105 000 $
-
-47 328 000 $
-
30/06/2018
3 913 000 $
-
-73 864 000 $
-
31/03/2018
6 246 000 $
-
-32 574 000 $
-
31/12/2017
20 407 000 $
-
48 445 000 $
-
30/09/2017
121 910 000 $
-
-2 061 000 $
-
30/06/2017
4 665 000 $
-
-14 187 000 $
-
Show:
to
Sorrento Therapeutics, Inc. financial report charts
The latest dates of Sorrento Therapeutics, Inc. financial statements available online: 30/06/2017, 31/12/2020, 31/03/2021. The dates of the financial statements are determined by the accounting rules. The latest financial report of Sorrento Therapeutics, Inc. is available online for such a date - 31/03/2021. Gross profit Sorrento Therapeutics, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Sorrento Therapeutics, Inc. is -32 964 000 $
Sorrento Therapeutics, Inc. quarterly report dates
Cost of revenue Sorrento Therapeutics, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Sorrento Therapeutics, Inc. is 47 219 000 $ Total revenue Sorrento Therapeutics, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Sorrento Therapeutics, Inc. is 14 255 000 $ Operating income Sorrento Therapeutics, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Sorrento Therapeutics, Inc. is -77 393 000 $
Net income Sorrento Therapeutics, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Sorrento Therapeutics, Inc. is 2 510 000 $ Current assets Sorrento Therapeutics, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Sorrento Therapeutics, Inc. is 265 701 000 $ Total assets Sorrento Therapeutics, Inc. refers to the total amount of assets owned by a person or entity. Total assets Sorrento Therapeutics, Inc. is 613 615 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-32 964 000 $
-25 109 000 $
-22 921 000 $
-17 392 000 $
-27 021 000 $
-18 863 000 $
-19 445 000 $
-14 155 000 $
-17 639 000 $
-15 238 000 $
4 935 000 $
19 427 000 $
120 825 000 $
3 849 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
47 219 000 $
36 614 000 $
34 674 000 $
26 399 000 $
32 799 000 $
25 340 000 $
25 588 000 $
21 084 000 $
21 744 000 $
19 151 000 $
1 311 000 $
980 000 $
1 085 000 $
816 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
14 255 000 $
11 505 000 $
11 753 000 $
9 007 000 $
5 778 000 $
6 477 000 $
6 143 000 $
6 929 000 $
4 105 000 $
3 913 000 $
6 246 000 $
20 407 000 $
121 910 000 $
4 665 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
5 778 000 $
6 477 000 $
6 143 000 $
6 929 000 $
4 105 000 $
3 913 000 $
6 246 000 $
20 407 000 $
121 899 000 $
4 571 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-77 393 000 $
-67 296 000 $
-48 220 000 $
-42 847 000 $
-53 246 000 $
-50 327 000 $
-47 837 000 $
-43 826 000 $
-38 396 000 $
-26 934 000 $
-32 546 000 $
-34 796 000 $
96 917 000 $
-13 458 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
2 510 000 $
-71 502 000 $
-84 023 000 $
-77 740 000 $
-64 415 000 $
-56 762 000 $
-108 071 000 $
-49 776 000 $
-47 328 000 $
-73 864 000 $
-32 574 000 $
48 445 000 $
-2 061 000 $
-14 187 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
-
-
-
-
-
-
76 963 000 $
76 963 000 $
76 963 000 $
14 632 000 $
37 865 000 $
17 506 000 $
11 179 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
91 648 000 $
78 801 000 $
59 973 000 $
51 854 000 $
59 024 000 $
56 804 000 $
53 980 000 $
50 755 000 $
42 501 000 $
30 847 000 $
37 481 000 $
54 223 000 $
23 908 000 $
17 307 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
265 701 000 $
86 234 000 $
105 988 000 $
55 001 000 $
67 568 000 $
93 506 000 $
118 579 000 $
179 564 000 $
145 245 000 $
54 746 000 $
36 569 000 $
29 700 000 $
44 708 000 $
60 595 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
613 615 000 $
535 822 000 $
602 085 000 $
533 068 000 $
560 875 000 $
587 043 000 $
609 474 000 $
624 087 000 $
587 964 000 $
452 521 000 $
436 879 000 $
431 613 000 $
484 784 000 $
384 768 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
41 678 000 $
56 464 000 $
75 176 000 $
24 388 000 $
34 649 000 $
61 385 000 $
90 971 000 $
158 738 000 $
135 441 000 $
46 784 000 $
24 252 000 $
20 429 000 $
38 323 000 $
53 681 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
112 713 000 $
111 989 000 $
74 082 000 $
61 621 000 $
82 410 000 $
39 399 000 $
1 594 000 $
-
2 407 000 $
-
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
-
-
24 696 000 $
20 870 000 $
39 211 000 $
54 337 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
554 206 000 $
532 427 000 $
491 361 000 $
416 587 000 $
364 404 000 $
193 056 000 $
7 095 000 $
-
26 982 000 $
-
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
98.81 %
90.70 %
80.62 %
66.75 %
61.98 %
42.66 %
1.62 %
-
5.57 %
-
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
231 436 000 $
165 151 000 $
205 440 000 $
137 285 000 $
45 895 000 $
83 529 000 $
131 943 000 $
209 472 000 $
221 592 000 $
254 371 000 $
234 805 000 $
199 568 000 $
131 021 000 $
92 422 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-45 831 000 $
-46 834 000 $
-44 309 000 $
-44 978 000 $
-20 704 000 $
-22 122 000 $
-23 963 000 $
-44 852 000 $
-12 664 000 $
-19 750 000 $
Last revenue report of Sorrento Therapeutics, Inc. was 31/03/2021. According to last financial report total revenue in Sorrento Therapeutics, Inc. was 14 255 000 US dollar and changed by +132.05% since last year. Net income in Sorrento Therapeutics, Inc. was 2 510 000 $ in last quartal, net income changes to 0%.
Current cash Sorrento Therapeutics, Inc. - the sum of all of the cash a company has on the date of report. Current cash Sorrento Therapeutics, Inc. is 41 678 000 $
Sorrento Therapeutics, Inc. stocks data
SRNE stock price
Sorrento Therapeutics, Inc. stock price today, SRNE stock quote.
